Maze Therapeutics Inc., a clinical-stage biopharmaceutical company, is set to participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference on July 14, 2025, at 2:30 p.m. ET. The company will engage in a fireside chat during the event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9492663-en) on July 10, 2025, and is solely responsible for the information contained therein.